These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 30479468
1. Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic review. Panes J, Reinisch W, Rupniewska E, Khan S, Forns J, Khalid JM, Bojic D, Patel H. World J Gastroenterol; 2018 Nov 14; 24(42):4821-4834. PubMed ID: 30479468 [Abstract] [Full Text] [Related]
2. Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas. Al-Maawali AK, Nguyen P, Phang PT. Can J Gastroenterol Hepatol; 2016 Nov 14; 2016():1651570. PubMed ID: 28053967 [Abstract] [Full Text] [Related]
4. Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy. Lahat A, Assulin Y, Beer-Gabel M, Chowers Y. J Crohns Colitis; 2012 Apr 14; 6(3):311-6. PubMed ID: 22405167 [Abstract] [Full Text] [Related]
12. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice. Bouchard D, Abramowitz L, Bouguen G, Brochard C, Dabadie A, de Parades V, Eléouet-Kaplan M, Fathallah N, Faucheron JL, Maggiori L, Panis Y, Pigot F, Rouméguère P, Sénéjoux A, Siproudhis L, Staumont G, Suduca JM, Vinson-Bonnet B, Zeitoun JD. Tech Coloproctol; 2017 Sep 07; 21(9):683-691. PubMed ID: 28929282 [Abstract] [Full Text] [Related]
13. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators. Lancet; 2016 Sep 24; 388(10051):1281-90. PubMed ID: 27477896 [Abstract] [Full Text] [Related]
15. Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease. Kotze PG, Spinelli A, Warusavitarne J, Di Candido F, Sahnan K, Adegbola SO, Danese S. Drugs Today (Barc); 2019 Feb 24; 55(2):95-105. PubMed ID: 30816884 [Abstract] [Full Text] [Related]
16. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial. Panés J, Bouma G, Ferrante M, Kucharzik T, Nachury M, de la Portilla de Juan F, Reinisch W, Selvaggi F, Tschmelitsch J, Brett NR, Ladouceur M, Binek M, Hantsbarger G, Campbell-Hill S, Karki C, Buskens C. Inflamm Bowel Dis; 2022 Nov 02; 28(11):1737-1745. PubMed ID: 35099555 [Abstract] [Full Text] [Related]
18. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series. Cabalzar-Wondberg D, Turina M, Biedermann L, Rogler G, Schreiner P. Colorectal Dis; 2021 Jun 02; 23(6):1444-1450. PubMed ID: 33595166 [Abstract] [Full Text] [Related]
19. [A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan]. Yamaguchi T. Nihon Yakurigaku Zasshi; 2024 Jun 02; 159(3):150-155. PubMed ID: 38692877 [Abstract] [Full Text] [Related]
20. Managing perianal Crohn's fistula in the anti-TNFα era. Tozer P, Borowski DW, Gupta A, Yassin N, Phillips R, Hart A. Tech Coloproctol; 2015 Nov 02; 19(11):673-8. PubMed ID: 26264168 [Abstract] [Full Text] [Related] Page: [Next] [New Search]